2024
Develop and validate a computable phenotype for the identification of Alzheimer's disease patients using electronic health record data
He X, Wei R, Huang Y, Chen Z, Lyu T, Bost S, Tong J, Li L, Zhou Y, Li Z, Guo J, Tang H, Wang F, DeKosky S, Xu H, Chen Y, Zhang R, Xu J, Guo Y, Wu Y, Bian J. Develop and validate a computable phenotype for the identification of Alzheimer's disease patients using electronic health record data. Alzheimer's & Dementia Diagnosis Assessment & Disease Monitoring 2024, 16: e12613. PMID: 38966622, PMCID: PMC11220631, DOI: 10.1002/dad2.12613.Peer-Reviewed Original ResearchElectronic health record dataElectronic health recordsComputable phenotypeHealth record dataManual chart reviewHealth recordsAlzheimer's diseaseDiagnosis codesRecord dataChart reviewUTHealthAlzheimer's disease patientsUniversity of MinnesotaAD diagnosisAD identificationDisease patientsPatientsAlzheimerAD patientsDemographicsDiagnosisDiseaseCodeDataUniversity
2022
Assess the documentation of cognitive tests and biomarkers in electronic health records via natural language processing for Alzheimer’s disease and related dementias
Chen Z, Zhang H, Yang X, Wu S, He X, Xu J, Guo J, Prosperi M, Wang F, Xu H, Chen Y, Hu H, DeKosky S, Farrer M, Guo Y, Wu Y, Bian J. Assess the documentation of cognitive tests and biomarkers in electronic health records via natural language processing for Alzheimer’s disease and related dementias. International Journal Of Medical Informatics 2022, 170: 104973. PMID: 36577203, DOI: 10.1016/j.ijmedinf.2022.104973.Peer-Reviewed Original ResearchConceptsElectronic health recordsPatients' electronic health recordsCognitive testsCognitive test scoresFlorida health systemSeverity categoriesHealth recordsAD-related dementiaAD/ADRD researchAD/ADRDPatient levelAlzheimer's diseaseClinical narrativesHealth systemBiomarkersDifferent severityDiseaseSeverityPatientsADRD researchStandardized approachDementiaTest scoresPopulation characteristicsScores
2021
Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States
Wijarnpreecha K, Li F, Xiang Y, Xu X, Zhu C, Maroufy V, Wang Q, Tao W, Dang Y, Pham H, Zhou Y, Li J, Zhang X, Xu H, Taner C, Yang L, Tao C. Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Alimentary Pharmacology & Therapeutics 2021, 54: 481-492. PMID: 34224163, DOI: 10.1111/apt.16490.Peer-Reviewed Original ResearchConceptsRisk of HCCBeta-blocker groupHepatocellular carcinomaCirrhotic patientsCerner Health Facts databaseCox proportional hazards regressionCumulative HCC incidenceRetrospective cohort studyHealth Facts databasePopulation-based studyProportional hazards regressionKaplan-Meier estimatesEligible patientsCohort studyHCC incidenceFinal cohortHazards regressionHCC riskLower riskPropensity scorePatientsCarvedilolRiskFacts databaseGroup